Back to: products

Asia Pacific Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application

PrintEmail
Jul 2021 - 105 Pages - From $2,800
(Excel Data Sheet: $1,500)
Description

The report cover may be different from the image shown.

Product and Price

By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.

Asia Pacific organ-on-chip market will grow by 35.1% annually with a total addressable market cap of $399.4 million over 2021-2030 owing to the rising use of organ-on-a-chip (OOC) in early detection of drug toxicity, increasing demand for personalized medicine, the emergence of OOC as an alternative to animal testing, the significant increase in research funding and venture capital investments.
Highlighted with 30 tables and 50 figures, this 105-page report “Asia Pacific Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific organ-on-chip market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific organ-on-chip market in every aspect of the classification from perspectives of Offering, Organ Type, Material, Application, End User, and Country.

Based on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Chips
• Service

Based on Organ Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Liver-on-a-Chip
• Heart-on-a-Chip
• Lung-on-a-Chip
• Kidney-on-a-Chip
• Brain-on-a-Chip
• Skin-on-a-Chip
• Vessels-on-a-Chip
• Other Organ Types

Based on Material, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Polymers
• Glass
• Silicon

Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Drug Discovery
• Toxicology Research
• Other Applications

Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Cosmetics Industry
• Other End Users

Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Organ Type, Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
AxoSim Inc.
BiomimX SRL
Cherry Biotech
CN Bio Innovations, Ltd.
Emulate Inc.
Hurel Corporation
InSphero AG
Kirkstall, Ltd.
MIMETAS BV
Nortis Inc.
Organovo, Inc.
SynVivo, Inc.
Tara Biosystems Inc.
TissUse GmbH
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter’s Fiver Forces Analysis 36
3 Segmentation of Asia Pacific Market by Offering 40
3.1 Market Overview by Offering 40
3.2 Chips 42
3.3 Service 43
4 Segmentation of Asia Pacific Market by Organ Type 44
4.1 Market Overview by Organ Type 44
4.2 Liver-on-a-Chip 46
4.3 Heart-on-a-Chip 47
4.4 Lung-on-a-Chip 48
4.5 Kidney-on-a-Chip 49
4.6 Brain-on-a-Chip 50
4.7 Skin-on-a-Chip 51
4.8 Vessels-on-a-Chip 52
4.9 Other Organ Types 53
5 Segmentation of Asia Pacific Market by Material 54
5.1 Market Overview by Material 54
5.2 Polymers 56
5.3 Glass 57
5.4 Silicon 58
6 Segmentation of Asia Pacific Market by Application 59
6.1 Market Overview by Application 59
6.2 Drug Discovery 61
6.3 Toxicology Research 62
6.4 Other Applications 63
7 Segmentation of Asia Pacific Market by End User 64
7.1 Market Overview by End User 64
7.2 Pharmaceutical and Biotechnology Companies 66
7.3 Academic and Research Institutes 67
7.4 Cosmetics Industry 68
7.5 Other End Users 69
8 Asia-Pacific Market 2019-2030 by Country 70
8.1 Overview of Asia-Pacific Market 70
8.2 Japan 73
8.3 China 76
8.4 Australia 78
8.5 India 80
8.6 South Korea 82
8.7 Rest of APAC Region 84
9 Competitive Landscape 86
9.1 Overview of Key Vendors 86
9.2 New Product Launch, Partnership, Investment, and M&A 89
9.3 Company Profiles 90
AxoSim Inc. 90
BiomimX SRL 92
Cherry Biotech 93
CN Bio Innovations, Ltd. 94
Emulate Inc. 95
Hurel Corporation 96
InSphero AG 97
Kirkstall, Ltd. 98
MIMETAS BV 99
Nortis Inc. 100
Organovo, Inc. 101
SynVivo, Inc. 102
Tara Biosystems Inc. 103
TissUse GmbH 104
RELATED REPORTS 105

List of Tables:

Table 1. Snapshot of Asia Pacific Organ-on-Chip Market in Balanced Perspective, 2019-2030 17
Table 2. Growth Rate of World GDP, 2020-2022 21
Table 3. World Health Spending by Region, $ bn, 2013-2020 28
Table 4. Main Product Trends and Market Opportunities in Asia Pacific Organ-on-Chip Market 32
Table 5. Asia Pacific Organ-on-Chip Market by Offering, 2019-2030, $ mn 40
Table 6. Asia Pacific Organ-on-Chip Market by Organ Type, 2019-2030, $ mn 44
Table 7. Asia Pacific Organ-on-Chip Market by Material, 2019-2030, $ mn 54
Table 8. Asia Pacific Organ-on-Chip Market by Application, 2019-2030, $ mn 59
Table 9. Asia Pacific Organ-on-Chip Market by End User, 2019-2030, $ mn 64
Table 10. APAC Organ-on-Chip Market by Country, 2019-2030, $ mn 71
Table 11. Japan Organ-on-Chip Market by Organ Type, 2019-2030, $ mn 75
Table 12. Japan Organ-on-Chip Market by Application, 2019-2030, $ mn 75
Table 13. Japan Organ-on-Chip Market by End User, 2019-2030, $ mn 75
Table 14. China Organ-on-Chip Market by Organ Type, 2019-2030, $ mn 77
Table 15. China Organ-on-Chip Market by Application, 2019-2030, $ mn 77
Table 16. China Organ-on-Chip Market by End User, 2019-2030, $ mn 77
Table 17. Australia Organ-on-Chip Market by Organ Type, 2019-2030, $ mn 79
Table 18. Australia Organ-on-Chip Market by Application, 2019-2030, $ mn 79
Table 19. Australia Organ-on-Chip Market by End User, 2019-2030, $ mn 79
Table 20. India Organ-on-Chip Market by Organ Type, 2019-2030, $ mn 81
Table 21. India Organ-on-Chip Market by Application, 2019-2030, $ mn 81
Table 22. India Organ-on-Chip Market by End User, 2019-2030, $ mn 81
Table 23. South Korea Organ-on-Chip Market by Organ Type, 2019-2030, $ mn 83
Table 24. South Korea Organ-on-Chip Market by Application, 2019-2030, $ mn 83
Table 25. South Korea Organ-on-Chip Market by End User, 2019-2030, $ mn 83
Table 26. Organ-on-Chip Market in Rest of APAC by Country/Region, 2019-2030, $ mn 85
Table 27. AxoSim Inc.: Company Snapshot 90
Table 28. AxoSim Inc.: Business Segmentation 90
Table 29. AxoSim Inc.: Product Portfolio 91
Table 30. AxoSim Inc.: Revenue, 2017-2019, $ mn 91

 

 

List of Figures:

Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 4. Asia Pacific Organ-on-Chip Market, 2019-2030, $ mn 19
Figure 5. Impact of COVID-19 on Business 22
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Organ-on-Chip Market 24
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 27
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 27
Figure 9. Primary Restraints and Impact Factors of Asia Pacific Organ-on-Chip Market 29
Figure 10. Investment Opportunity Analysis 33
Figure 11. Porter’s Fiver Forces Analysis of Asia Pacific Organ-on-Chip Market 36
Figure 12. Breakdown of Asia Pacific Organ-on-Chip Market by Offering, 2019-2030, % of Revenue 41
Figure 13. Asia Pacific Addressable Market Cap in 2021-2030 by Offering, Value ($ mn) and Share (%) 41
Figure 14. Asia Pacific Organ-on-Chip Market: Chips, 2019-2030, $ mn 42
Figure 15. Asia Pacific Organ-on-Chip Market: Service, 2019-2030, $ mn 43
Figure 16. Breakdown of Asia Pacific Organ-on-Chip Market by Organ Type, 2019-2030, % of Sales Revenue 45
Figure 17. Asia Pacific Addressable Market Cap in 2021-2030 by Organ Type, Value ($ mn) and Share (%) 45
Figure 18. Asia Pacific Organ-on-Chip Market: Liver-on-a-Chip, 2019-2030, $ mn 46
Figure 19. Asia Pacific Organ-on-Chip Market: Heart-on-a-Chip, 2019-2030, $ mn 47
Figure 20. Asia Pacific Organ-on-Chip Market: Lung-on-a-Chip, 2019-2030, $ mn 48
Figure 21. Asia Pacific Organ-on-Chip Market: Kidney-on-a-Chip, 2019-2030, $ mn 49
Figure 22. Asia Pacific Organ-on-Chip Market: Brain-on-a-Chip, 2019-2030, $ mn 50
Figure 23. Asia Pacific Organ-on-Chip Market: Skin-on-a-Chip, 2019-2030, $ mn 51
Figure 24. Asia Pacific Organ-on-Chip Market: Vessels-on-a-Chip, 2019-2030, $ mn 52
Figure 25. Asia Pacific Organ-on-Chip Market: Other Organ Types, 2019-2030, $ mn 53
Figure 26. Breakdown of Asia Pacific Organ-on-Chip Market by Material, 2019-2030, % of Sales Revenue 55
Figure 27. Asia Pacific Addressable Market Cap in 2021-2030 by Material, Value ($ mn) and Share (%) 55
Figure 28. Asia Pacific Organ-on-Chip Market: Polymers, 2019-2030, $ mn 56
Figure 29. Asia Pacific Organ-on-Chip Market: Glass, 2019-2030, $ mn 57
Figure 30. Asia Pacific Organ-on-Chip Market: Silicon, 2019-2030, $ mn 58
Figure 31. Breakdown of Asia Pacific Organ-on-Chip Market by Application, 2019-2030, % of Revenue 60
Figure 32. Asia Pacific Addressable Market Cap in 2021-2030 by Application, Value ($ mn) and Share (%) 60
Figure 33. Asia Pacific Organ-on-Chip Market: Drug Discovery, 2019-2030, $ mn 61
Figure 34. Asia Pacific Organ-on-Chip Market: Toxicology Research, 2019-2030, $ mn 62
Figure 35. Asia Pacific Organ-on-Chip Market: Other Applications, 2019-2030, $ mn 63
Figure 36. Breakdown of Asia Pacific Organ-on-Chip Market by End User, 2019-2030, % of Revenue 65
Figure 37. Asia Pacific Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%) 65
Figure 38. Asia Pacific Organ-on-Chip Market: Pharmaceutical and Biotechnology Companies, 2019-2030, $ mn 66
Figure 39. Asia Pacific Organ-on-Chip Market: Academic and Research Institutes, 2019-2030, $ mn 67
Figure 40. Asia Pacific Organ-on-Chip Market: Cosmetics Industry, 2019-2030, $ mn 68
Figure 41. Asia Pacific Organ-on-Chip Market: Other End Users, 2019-2030, $ mn 69
Figure 42. Breakdown of APAC Organ-on-Chip Market by Country, 2019 and 2030F, % of Revenue 71
Figure 43. Contribution to APAC 2021-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 72
Figure 44. Organ-on-Chip Market in Japan, 2019-2030, $ mn 74
Figure 45. Organ-on-Chip Market in China, 2019-2030, $ mn 76
Figure 46. Organ-on-Chip Market in Australia, 2019-2030, $ mn 78
Figure 47. Organ-on-Chip Market in India, 2019-2030, $ mn 80
Figure 48. Organ-on-Chip Market in South Korea, 2019-2030, $ mn 82
Figure 49. Organ-on-Chip Market in Rest of APAC, 2019-2030, $ mn 84
Figure 50. Growth Stage of Asia Pacific Organ-on-Chip Industry over the Forecast Period 86

 

Reviews

There are yet no reviews for this product.